Transce3nd’s Colgate-Palmolive CL Stock Holding History

Transce3nd’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-464	Closed	-$42.2K	–	321
2025 Q2	$42.2K	Hold	464	–	–	0.02%	313
2025 Q1	$43.5K	Hold	464	–	–	0.02%	300
2024 Q4	$42.2K	Buy	+464	New	+$44.3K	0.01%	405

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Transce3nd's CL Position: Q3 2025 in Review

Transce3nd sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 464 shares — an estimated $42.2K sold.

Transce3nd first reported a position in CL in Q4 2024 and held it in 3 quarters. The position peaked at $43.5K in Q1 2025. 1,845 funds tracked by Wall St. Rank hold CL as of Q3 2025.

Transce3nd reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 464 Colgate-Palmolive shares in Q3 2025, an estimated $42.2K.
Transce3nd first reported a position in Colgate-Palmolive in Q4 2024 and held it in 3 quarters.
Transce3nd's Colgate-Palmolive position peaked at $43.5K in Q1 2025.
1,845 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.